Significant Losses Recorded for Perspective Therapeutics and Pyxis Oncology, Down by 44.33% and 42.93%

2 min read | November 21, 2024 10:03 PM PST | By Team Kalkine Media

Google News:

Significant Losses Recorded for Perspective Therapeutics and Pyxis Oncology, Down by 44.33% and 42.93% — Image source: Shutterstock

Recent News

JPMorgan (NYSE:JPM) Leads Quiet Rotation In Financial Value Stocks

Exxon Mobil (NYSE:XOM) In Focus: What’s Catching Market Attention?

UnitedHealth (NYSE:UNH) Leads Healthcare Value Watch

Duke Energy (NYSE:DUK) Dividends Face A Key Market Test

Make Kalkine Media
My Trusted Source

Highlights:

SKK Holdings Limited (SKK) experienced a significant decline of −53.95%.

Perspective Therapeutics, Inc. (CATX) sees a notable drop of −44.33%.

Agrify Corporation (AGFY) faces a decrease of −26.55%, along with other biotech stocks.

SKK Holdings Limited (SKK) has encountered a sharp decline, falling by 53.95%, with its current trading price at 2.10 USD. The company now holds a market capitalization of 11.83 million USD. This drop is part of a broader trend affecting some smaller and mid-cap companies in the market.

Perspective Therapeutics, Inc. (NYSE:CATX), another biotech firm, is also facing a significant downturn. The stock has dropped by 44.33%, with a market cap of 232.16 million USD. This decline follows challenges in the biotech sector, where investor sentiment has been fluctuating.

Pyxis Oncology, Inc. (PYXS) has decreased by 42.93%, trading at 2.18 USD. This decline reflects the challenges that biopharma companies continue to face, especially within the oncology sector. Despite the recent downturn, Pyxis Oncology maintains a market capitalization of 129.64 million USD.

TMT Acquisition Corp (TMTC), a special purpose acquisition company (SPAC), has seen a drop of 37.73%, with a market cap of 17.33 million USD. SPACs, in particular, have been under pressure due to increased scrutiny and fluctuating investor confidence.

Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company focused on oncology therapies, has also been impacted, dropping 32.62%. The stock is currently priced at 10.72 USD, with a market capitalization of 833.63 million USD.

Lastly, Agrify Corporation (AGFY), which focuses on providing innovative cultivation technologies for the cannabis industry, has decreased by 26.55%. The stock is trading at 28.47 USD, with a market cap of 43.55 million USD.

These declines reflect broader market trends and challenges faced by companies in specific sectors, such as biotechnology and cannabis, where market conditions and investor sentiment can significantly impact stock performance.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.